Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
How do you help patients understand the difference between prolonged morning stiffness and pain?
Related Questions
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
Do you combine methotrexate and leflunomide for the treatment of RA?
What is your approach to biologic therapy in older adults (80+) and CKD with RA?
Do you consider Anti-carbamylated protein antibodies (anti-CarP) as having any significance in evaluation of patients if RF and ACPA negative and clinically no active synovitis yet widespread arthralgias and generalized osteoarthritis?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
How do you approach treating a patient with RA and cirrhosis who did not respond to csDMARDs?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
Do you use the peri-operative management of biologics and DMARDs guidelines, which were mainly based on total hip and knee replacement surgeries, for all peri-operative surgical management?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
How do you approach the timing of DMARD initiation in patients with active RA who are on treatment for latent TB?
